Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an ab...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2006
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872006000400001 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720060004000012014-01-23Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecalMancilla A,CarlaHurtado H,CarmenTobar A,EduardoOrellana N,IvonnePineda B,PedroCastillo M,IvánLedezma R,RodrigoBerger F,Zoltán Diabetes mellitus Pancreatic elastase Pancreatitis, chronic Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an abdominal CAT scan showed a chronic calcified pancreatitis, previously undiagnosed. Fecal elastase was measured by ELISA and the presence of fat in feces was assessed using the steatocrit. Results: Mean age was 60±12 years and 67 (96%) patients had a type 2 diabetes. Fecal elastase was normal (elastase >200 µg/g) in 47 (67%) patients, mildly decreased (100-200 µg/g) in 10 (14%) and severely decreased in 13 (19%). There was a significant association between elastase levels and time of evolution of diabetes (p=0.049) and between lower elastase levels and the presence of a positive steatocrit (p=0.042). No significant association was found between elastase levels and other chronic complications of diabetes such as retinopathy, nephropathy, neuropathy, microangiopathy or with insulin requirement. Conclusions: One third of this group of diabetic patients had decreased levels of fecal elastase, that was associated with the time of evolution of diabetes. Patients with lower levels of elastase have significantly more steatorrhea. Among diabetics it is possible to find a group of patients with non diagnosed chronic pancreatitisinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.4 20062006-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001es10.4067/S0034-98872006000400001 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Diabetes mellitus Pancreatic elastase Pancreatitis, chronic |
spellingShingle |
Diabetes mellitus Pancreatic elastase Pancreatitis, chronic Mancilla A,Carla Hurtado H,Carmen Tobar A,Eduardo Orellana N,Ivonne Pineda B,Pedro Castillo M,Iván Ledezma R,Rodrigo Berger F,Zoltán Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
description |
Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an abdominal CAT scan showed a chronic calcified pancreatitis, previously undiagnosed. Fecal elastase was measured by ELISA and the presence of fat in feces was assessed using the steatocrit. Results: Mean age was 60±12 years and 67 (96%) patients had a type 2 diabetes. Fecal elastase was normal (elastase >200 µg/g) in 47 (67%) patients, mildly decreased (100-200 µg/g) in 10 (14%) and severely decreased in 13 (19%). There was a significant association between elastase levels and time of evolution of diabetes (p=0.049) and between lower elastase levels and the presence of a positive steatocrit (p=0.042). No significant association was found between elastase levels and other chronic complications of diabetes such as retinopathy, nephropathy, neuropathy, microangiopathy or with insulin requirement. Conclusions: One third of this group of diabetic patients had decreased levels of fecal elastase, that was associated with the time of evolution of diabetes. Patients with lower levels of elastase have significantly more steatorrhea. Among diabetics it is possible to find a group of patients with non diagnosed chronic pancreatitis |
author |
Mancilla A,Carla Hurtado H,Carmen Tobar A,Eduardo Orellana N,Ivonne Pineda B,Pedro Castillo M,Iván Ledezma R,Rodrigo Berger F,Zoltán |
author_facet |
Mancilla A,Carla Hurtado H,Carmen Tobar A,Eduardo Orellana N,Ivonne Pineda B,Pedro Castillo M,Iván Ledezma R,Rodrigo Berger F,Zoltán |
author_sort |
Mancilla A,Carla |
title |
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
title_short |
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
title_full |
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
title_fullStr |
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
title_full_unstemmed |
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal |
title_sort |
función pancreática exocrina en diabetes mellitus: determinación de elastasa fecal |
publisher |
Sociedad Médica de Santiago |
publishDate |
2006 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001 |
work_keys_str_mv |
AT mancillaacarla funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT hurtadohcarmen funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT tobaraeduardo funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT orellananivonne funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT pinedabpedro funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT castillomivan funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT ledezmarrodrigo funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal AT bergerfzoltan funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal |
_version_ |
1718436254247288832 |